Trailing-twelve-month (TTM) revenue is $1.44 Billion with a year-over-year growth of +6.54%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-28 | $364,526,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-28 | $349,393,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-04-05 | $331,037,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-07-05 | $395,698,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $1,440,654,000 |
Current P/S: $2,034,869,530 market capitalization ÷ $1,440,654,000 TTM revenue = 1.41x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-07-05.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-05): $395.70M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:43:18.987Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-29 · USD | FY20252025-12-28 · USD |
|---|---|---|
| AMS | $801M | $844M |
| EAAA | $515M | $543M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-03 · USD | FY20212022-01-02 · USD | FY20222023-01-01 · USD | FY20232023-12-31 · USD | FY20242024-12-29 · USD | FY20252025-12-28 · USD |
|---|---|---|---|---|---|---|
| Americas | $593M | N/A | N/A | N/A | N/A | N/A |
| AMS | N/A | N/A |
$1.44B
$1.44 Billion
+6.54%
vs. $1.35B a year ago (TTM)
+5.47%
5 Year compound annual growth rate
1 Year
+6.54%
3 Year
+3.77%
5 Year
+5.47%
10 Year
+4.01%
15 Year
+3.08%
20 Year
+1.77%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.39B | +$71.20M | +5.41% |
| 2024 | $1.32B | +$54.16M | +4.29% |
| 2023 | $1.26B | ($36.42M) | (2.81%) |
| 2022 | $1.30B | +$97.52M | +8.12% |
| 2021 | $1.20B | +$97.14M | +8.80% |
| 2020 |
TTM Growth
+6.54%
3-Year CAGR
+3.77%
5-Year CAGR
+5.47%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T20:43:18.987Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $737M |
| $801M |
| $844M |
| Asia Pacific | $159M | N/A | N/A | N/A | N/A | N/A |
|---|
| EAAA | N/A | N/A | $544M | $525M | $515M | $543M |
|---|
| Europe | $351M | N/A | N/A | N/A | N/A | N/A |
|---|
| Foreign Countries Other Than United States And Germany | N/A | $488M | N/A | N/A | N/A | N/A |
|---|
| GERMANY | N/A | $116M | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | $597M | N/A | N/A | N/A | N/A |
|---|
| $1.10B |
| ($239.77M) |
| (17.85%) |
| 2019 | $1.34B | +$163.46M | +13.86% |
| 2018 | $1.18B | +$183.13M | +18.38% |
| 2017 | $996.44M | +$37.83M | +3.95% |
| 2016 | $958.62M | ($43.25M) | (4.32%) |
